GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
复制标题
GCN2 缺陷通过减少心肌细胞凋亡和心肌氧化应激来改善阿霉素诱导的心脏毒性。
DOI:
10.1016/j.redox.2018.04.009
复制
发表时间:
2018-07
期刊:
影响因子:
11.4
通讯作者:
Lu Z
中科院分区:
文献类型:
--
作者:
Wang Y;Lei T;Yuan J;Wu Y;Shen X;Gao J;Feng W;Lu Z
The clinical use of doxorubicin for cancer therapy is limited by its cardiotoxicity, which involves cardiomyocyte apoptosis and oxidative stress. Previously, we showed that general control nonderepressible 2 (GCN2), an eukaryotic initiation factor 2α (eIF2α) kinase, impairs the ventricular adaptation to chronic pressure overload by affecting cardiomyocyte apoptosis. However, the impact of GCN2 on Dox-induced cardiotoxicity has not been investigated. In the present study, we treated wild type (WT) and Gcn2−/− mice with four intraperitoneal injections (5 mg/kg/week) to induce cardiomyopathy. After Dox treatment, Gcn2−/− mice developed less contractile dysfunction, myocardial fibrosis, apoptosis, and oxidative stress compared with WT mice. In the hearts of the Dox-treated mice, GCN2 deficiency attenuated eIF2α phosphorylation and induction of its downstream targets, activating transcription factor 4 (ATF4) and C/EBP homologous protein (CHOP), and preserved the expression of anti-apoptotic factor Bcl-2 and mitochondrial uncoupling protein-2(UCP2). Furthermore, we found that GCN2 knockdown attenuated, whereas GCN2 overexpression exacerbated, Dox-induced cell death, oxidative stress and reduction of Bcl-2 and UCP2 expression through the eIF2α-CHOP-dependent pathway in H9C2 cells. Collectively, our data provide solid evidence that GCN2 has a marked effect on Dox induced myocardial apoptosis and oxidative stress. Our findings suggest that strategies to inhibit GCN2 activity in cardiomyocyte may provide a novel approach to attenuate Dox-related cardiotoxicity. GCN2 deficiency ameliorates doxorubicin-induced cardiac dysfunction. GCN2 promotes doxorubicin-induced cardiomyocyte apoptosis and oxidative stress. GCN2 decreases Bcl-2 and UCP2 expression via a CHOP dependent manner. Knockdown of UCP2 exacerbated doxorubicin-induced cell death and oxidative stress.
登录
查看更多内容
影响因子:
3.4
作者:
McGowan JV;Chung R;Maulik A;Piotrowska I;Walker JM;Yellon DM
通讯作者:
Yellon DM
影响因子:
3.3
作者:
Wei C;Lin M;Jinjun B;Su F;Dan C;Yan C;Jie Y;Jin Z;Zi-Chun H;Wu Y
通讯作者:
Wu Y
影响因子:
21.3
作者:
通讯作者:
--
影响因子:
16
作者:
Harding, HP;Novoa, I;Ron, D
通讯作者:
Ron, D
影响因子:
64.8
作者:
Costa-Mattioli, M;Gobert, D;Sonenberg, N
通讯作者:
Sonenberg, N